Heart rate variation and movement incidence in growth-retarded fetuses: the significance of antenatal late heart rate decelerations

In 37 intrauterine growth-retarded fetuses, combined 1-hour recordings of fetal heart rate and body movements were made within 24 hours of elective cesarean section. Fetal body movements were recorded simultaneously by use of real-time ultrasound. The study group was divided into two subgroups, according to the presence (n = 29) or absence (n = 8) of antepartum late heart rate decelerations. Correlations were made with umbilical blood gas values obtained immediately after cesarean section. Baseline heart rate variation was reduced below the normal range in 88% of the intrauterine growth-retarded fetuses with decelerations but in only 37% of the group without decelerations. A reduction in fetal heart rate accelerations and body movements and an increase in mean heart rate also were observed only in the group with decelerations. Late heart rate decelerations were associated with low PO2 values in both umbilical artery and vein. It is concluded that in intrauterine growth-retarded fetuses reduced heart rate variation and movement incidence correlate with the presence of late heart rate decelerations before birth and with hypoxemia at birth.     

Longitudinal measurements of fetal breathing, body movements, heart rate, and heart rate accelerations and decelerations at 24 to 32 weeks of gestation

Fetal breathing, fetal body movements, fetal heart rate, and fetal heart rate accelerations and decelerations were studied longitudinally in healthy fetuses between 24 and 32 weeks' gestation in the second and third hour following an 800 kcal maternal meal. The expected increase in fetal breathing following a maternal meal was not seen until fetuses were at 30 to 32 weeks' gestation. The number of body movements decreased and the interaction between body movements and fetal heart rate accelerations became more evident as fetuses became older. Fetal heart rate decelerations increased with gestational age, and the relative proportion of total decelerations that were either associated with body movements or were part of a deceleration/acceleration/deceleration complex increased from 24 to 32 weeks' gestation. The data support the hypothesis that gestational age is an important variable to consider when interpreting biophysical measurements in the human fetus at 24 to 32 weeks' gestation. Fetal body movements may be the single most important measurement of fetal health at these gestational ages.     

Normal fetal physiology and behavior, and adaptive responses with hypoxemia

The principal objective of antenatal testing is to detect fetal hypoxia before the fetus has suffered lasting harm. This article summarizes some of the mechanisms by which fetal oxygen consumption is maintained under normal conditions, and adaptations that occur in response to hypoxemia. Alterations in the fetal heart rate are prominent in the fetal response to hypoxemia and are the basis of some methods of antenatal testing. The principal mechanisms underlying these fetal heart rate changes are described. Adaptations in the distribution of blood flow that permit the fetus to deal with reduced oxygen levels are summarized. Developmental trends in fetal motility and behavior are outlined, and also how these are modified by fetal growth retardation and maternal diabetes. Fetal movements are suppressed during acute hypoxemia, but with gradually developing hypoxemia, normal movement patterns may continue until the fetus becomes acidemic. This may limit the use of these biophysical variables in antenatal testing.     

Description of cardiogram potentials of fetal movements in labor

Examples of cardiographic reflections of intranatal fetal movements (body movements) in 130 normotrophic and 26 hypotrophic fetuses (body weight less than or equal to 10th percentile) are presented. Labour-synchronous accelerations of fetal heart rate occurred in 95% associated with fetal body movements. About 83% of the body movements associated with fetal heart rate accelerations occurred periodically. Strikingly, labour with fetal body movements resulted in accelerations, whereas labour alone hardly ever produced medium-term heart rate changes or variable decelerations. In contrast to periodical accelerations with associated body movements, periodical accelerations without associated fetal body movements, which are mainly of hemodynamic origin, indicated potential fetal risk. Even with medium-degree or severe variable decelerations in the expulsive period, fetal body movements with associated heart rate accelerations indicated a good actual fetal condition. The importance of cardiogram synchronous real-time ultrasonic examination of intranatal fetal movements is discussed.     

Effect of prolonged hypoxemia on fetal heart rate accelerations and decelerations in sheep

Experiments were conducted in 10 chronically catheterized fetal sheep to determine the effect of 24 hours of hypoxemia in the absence of progressive acidemia on fetal heart rate accelerations and decelerations. Fetal hypoxemia was produced by mechanically restricting uterine blood flow with a vascular clamp placed around the maternal common internal iliac artery. Fetal arterial oxygen tension decreased from 22.3 +/- 1.8 to 17.8 +/- 1.5 mm Hg at 2 hours and remained low for the 24-hour experimental period. Fetal pH decreased from 7.34 +/- 0.01 to 7.20 +/- 0.05 at 2 hours and returned to normal values by 12 hours. No significant change was observed in the number or characteristics of fetal heart rate accelerations or decelerations during the 24-hour control period. There was a significant increase in the number of accelerations from 48 +/- 4 to 63 +/- 4 per hour at 8 hours of hypoxemia followed by a return to control values by 12 hours. There was no significant change in the mean amplitude or duration of accelerations. There was a significant increase in the number of decelerations per hour with an associated increase in the mean amplitude but a decrease in the mean duration of decelerations during the first 16 hours of hypoxemia. We conclude that prolonged hypoxemia in fetal sheep leads to an initial increase in the number of both accelerations and decelerations in fetal heart rate followed by a return to normal patterns indistinguishable from those of the normoexemic fetus.     

Braxton Hicks' contractions and motor behavior in the near-term human fetus

The transient relationship between Braxton Hicks' contractions and fetal motor behavior was studied in 14 healthy nulliparous women near term. Two-hour recordings of fetal heart rate and uterine contractions and of real-time scanning for fetal body movements, breathing, and eye movements were made. The recordings were divided into state 1F and non-state 1F. Braxton Hicks' contractions were not influenced by fetal behavioral states and state changes were not related to these contractions. Fetal body movements did not stimulate contractions, but contractions coincided with a specific clustering of body movements during the ascending part of contractions. Breathing was clustered during the descending part of short-lasting contractions but decreased gradually during the long-lasting ones. Heart rate variation was increased during contractions.     

The relationship between antepartum fetal heart rate, intrapartum fetal heart rate, and fetal acid-base status

The relationships between antepartum baseline fetal heart rate, baseline variability, accelerations, decelerations, and fetal movement and intrapartum fetal heart rate, fetal acid-base assessment at delivery, and Apgar scores 1 and 5 minutes after delivery were studied in 290 mature pregnancies. There was a significant relationship between antepartum and intrapartum baseline fetal heart rate and baseline variability. There was no relationship between antepartum and intrapartum accelerations or decelerations. There was no correlation between antepartum fetal heart rate or fetal movement and fetal acid-base status at delivery or Apgar scores 1 and 5 minutes after delivery. There was a trend for decreased accelerations and decreased fetal movements to be associated with a low Apgar score 1 minute after delivery.     

Qualitative description of cardiogram potentials of fetal body and respiratory movements in the non-contracting uterus

Cardiographic reflections of fetal movements were assessed using cardiogram synchronous ultrasonic examination in 44 normotrophic and 40 hypotrophic fetuses with body weights less than or equal to 10th percentile. The study showed that 90% of the fetal body movements were associated with accelerations in fetal heart rate. The degree of associated accelerations depended on the duration of the fetal body movements. In the hypotrophic fetuses the associated heart rate accelerations had a lower amplitude and a relatively longer duration. In impaired fetuses body movements were associated with decelerations in heart rate. Fetal respiratory movements resulted in an increasing beat-to-beat variability in the CTG. This effect did not occur constantly. During prolonged fetal respiratory segments no fetal body movements were observed and vice versa. Possible causes for the association between fetal movements and cardiogram are discussed.     

V-shaped deceleration differs in the pattern of carotid blood flow from variable deceleration provoked by cord compression

OBJECTIVE: To investigate whether V-shaped decelerations in fetal heart rate tracing are a physiologic response to fetal movements or secondary to cord compression. STUDY DESIGN: Six pregnant sheep and their fetuses (115-125 days of gestation) were surgically instrumented and studied. Fetal electrocardiogram, carotid blood flow, arterial blood pressure and fetal movement were continuously monitored for 24 hours. Following the undisturbed 24 hour recording, these parameters were monitored during umbilical cord compression (n = 6). Differences in these parameters between V-shaped decelerations and decelerations provoked by cord compressions were examined. RESULTS: Elevation of blood pressure and decreased carotid blood flow were observed coincidentally with the initiation of V-shaped decelerations. In cord compression, elevation of both blood pressure and carotid blood flow were followed by a decreased heart rate. V-shaped decelerations exhibited a different alteration of carotid blood flow compared to decelerations caused by umbilical cord compression. CONCLUSION: V-shaped deceleration is a physiologic response secondary mainly to fetal movements and is not caused by cord compression.     

A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate

Objective To compare the effects of maternal administration of betamethasone and dexamethasone on fetal heart rate, using computerised numerical analyses, and to examine the association between changes in short term variation and the timing and indication for delivery.
Setting John Radcliffe Hospital, Oxford.
Sample Fifty-nine women with singleton pregnancies, who were at risk of delivery before 34 weeks of gestation, had received no steroids in the preceding week and could give informed consent.
Methods Women were randomised on a double-blind basis to receive either betamethasone or dexamethasone. The fetal heart rate was recorded (60-minute duration at similar times of day) before steroid administration and on each of the following two days; changes were measured by computerised analyses.
Main outcome measures Changes in short term variation and long term variation of fetal heart rate or the number of fetal movements. Statistical analysis was nonparametric.
Results Betamethasone and dexamethasone had no differential effects on the computerised cardiotocography. However, both steroids decreased baseline fetal heart rate, increased long term variation, increased short term variation, and decreased fetal movements on the first day after steroid administration, and decreased high fetal heart rate variation and decelerations on the second day. Among 13 women who were delivered within one week of steroid administration, smaller rises in short term variation on day one were associated with delivery for fetal indications.
Conclusions Both betamethasone and dexamethasone produced transient, unexplained changes in the fetal heart rate over the two days following steroid administration. Larger changes in short term variation were associated with fetal wellbeing. It is important to recognise that such changes are a physiological response of the human fetus to steroid administration.     

Fetal monitoring during emergency obstetric transport

The practicality of fetal heart rate monitoring during fixed-wing transport of obstetric emergencies was evaluated. Fifty-seven transports were performed and 40 (70%) were monitored successfully with the electronic fetal heart rate monitor. External fetal heart rate monitoring was technically accomplished in 83% of monitored transports. Of the 40 patients monitored, 33 (83%) of the fetal heart rate tracings were considered useful for adequate evaluation of the fetal heart rate and contraction frequency. No patients had late decelerations during transport. At cabin pressures from 1100 feet to 7000 feet, fetal hypoxia as measured by late decelerations was not present in any patient.     

The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial.

BACKGROUND; Contradictory findings on the effect of betamethasone versus dexamethasone on antenatal tests of fetal well-being have been reported. The purpose of this study was to compare the effects of these steroid compounds on fetal heart rate patterns and biophysical activities in a prospective. randomized trial. STUDY DESIGN: Forty-six pregnant women (gestational age range 27-34 weeks) at risk for preterm delivery were randomized to receive betamethasone or dexamethasone for enhancement of fetal lung maturity. Fetal heart rate was recorded for 60 minutes and analyzed with the Sonicaid System 8000 before (0 hours), and 48 hours and 96 hours after steroid administration. Subsequently, fetal limb, body and breathing movements were sonographically observed and quantified for 30 minutes. To account for fetal circadian rhythms, all examinations were performed between 1 p.m. and 5 p.m., at least one hour after maternal meals. RESULTS: Fetal heart rate accelerations (p<0.001; p<0.01), short-term variation (p<0.0001; p<0.05), long-term variation (p<0.01; p=NS), duration of high episodes (p<0.001; p<0.05), total movement count (p<0.001; p<0.05), and duration of breathing time (p<0.0001; p<0.0001) were substantially reduced 48 h after betamethasone and dexamethasone administration, respectively, with percent reduction being larger for the betamethasone group, except for breathing movements (p<0.05; p<0.001; p<0.001; p<0.005; p<0.05; p=NS; respectively). In 68.2%( and 45.5% of fetuses, less than 30 seconds of continuous breathing movements were found in the betamethasone and dexamethasone groups, respectively. In 71.8% and 12.5%, of fetuses, respectively, less than 2 body/limb movements were observed. Therefore five and two fetuses in the betamethasone and dexamethasone study group, respectively, had both nonreactive fetal heart rate monitors for 60 minutes and biophysical profiles of < or =4/10. All parameters returned to baseline values at 96 h. Baseline fetal heart rate and numbers of decelerations remained unchanged (p=NS). CONCLUSIONS: Both betamethasone and dexamethasone induce a profound, albeit transient, suppression of fetal heart rate characteristics and biophysical activities in the preterm fetus. However, the effect of betamethasone is more pronounced. Awareness of these phenomena might prevent unwarranted iatrogenic delivery of preterm fetuses.     

Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone

Objectives To compare the effects of maternal betamethasone and dexamethasone administration on fetal behaviour and fetal heart rate variation.
Design Aprospective randomised study of 60 women at increased risk of preterm delivery.
Outcome measures Fetal heart rate and its variation, the incidence of fetal body and breathing movements.
Setting Obstetric unit, University Hospital, Utrecht, The Netherlands.
Results Following maternal betamethasone administration (day 2), fetal heart rate variation was reduced by 19% and fetal body and breathing movements by 49% and 85%, respectively. After dexamethasone treatment there was a significant increase in short term fetal heart rate variation (24%) on day 1. All values returned to baseline on day 4, indicating that no fetal deterioration had occurred during the course of the study period.
Conclusion Betamethasone, with probably the greater beneficial effect, has more effects on fetal behaviour and fetal heart rate variation than dexamethasone. When assessing fetal condition, due account needs to be taken of these effects.     

Movement and heart acceleration behavior of eutrophic fetuses in the early and late dilatation period

The degree of fetal respiratory and body movements as well as of fetal heart rate reactivity was checked by synchronous ultrasonic and cardiographic monitoring of 18 normotrophic fetuses in the early and late dilation period. Apart from the fetal respiratory movements, which could no longer be observed in the late dilatation period, the degree of fetal body movements remained unaffected during the birth process. In the late dilatation period, the mean amplitude of heart rate accelerations occurring in association with fetal body movements was significantly lower than in the early dilatation period. In the unimpaired normotrophic fetus, however, the reactivity of the fetal cardiovascular system increased during the birth process in relation to the ratio of the amplitude of heart rate accelerations and the duration of associated fetal body movements. Hence, a decrease in fetal heart rate reactivity signals intranatal disturbance of the materno-utero-placento-fetal entity.     

Temporal changes in fetal cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation fetal sheep.

OBJECTIVE: To determine the primary (0-12 h) and secondary (12-24 h) effects of dexamethasone on fetal heart rate, short term heart rate variation, blood pressure, breathing movements and electrocortical activity, blood gas exchange, metabolism and adrenocortical function in the late gestation sheep fetus. DESIGN: Comparison of the effects of a single maternally administered intramuscular injection of dexamethasone (12 mg) with those of saline vehicle from 1 h before injection to 24 h post-injection. Fetal cardiovascular and behavioural parameters were recorded continuously. Fetal and maternal blood samples were taken at regular intervals for blood gas, glucose and lactate, cortisol and adrenocorticotrophin measurements. SAMPLE: Sixteen chronically instrumented singleton fetal sheep at 127-133 days of gestation (term is about 147 days). RESULTS: During the primary phase short term heart rate variation fell (P < 0.001), and this was associated with a transient fall in the incidence of fetal breathing movements, a fall in fetal heart rate and a rise in fetal blood pressure. By 12 h there was a significant increase in short term heart rate variation (P < 0.001) and a rise in fetal heart rate, but blood pressure and fetal breathing movements had returned to normal. Dexamethasone significantly reduced fetal PaO2 throughout most of the experimental period, particularly 1 h post-injection (P < 0.005). Fetal and maternal plasma cortisol and adrenocorticotrophin concentrations fell significantly from 1 h post-injection. CONCLUSIONS: The effects of dexamethasone on fetal heart rate variation are more complex than previously described with both a fall and an increase observed depending on the time at which heart rate variation was measured after injection. Dexamethasone also caused a significant fall in fetal PaO2, and although this was not to hypoxic levels in normoxic fetuses it does raise questions about the potential impact of dexamethasone on chronically hypoxic fetuses.     

Mechanisms of late decelerations in the fetal heart rate. A study with autonomic blocking agents in fetal lambs.

Fetal heart rate decelerations resembling the late deceleration FHR pattern were produced in fetal sheep by periodic occlusion of the maternal common hypogastric artery for 30-60 sec. Transient fetal hypertension also occurred during the occlusions. Alpha-adrenergic blockade with phentolamine eliminated or markedly reduced the hypertensive response. FHR decelerations still occurred intermittently with some occlusions; however, their character was greatly altered. After parasympathetic blockade with atropine, the decelerations were replaced by periodic FHR accelerations during the occlusions. These accelerations were, in turn, eliminated by the beta-adrenergic blocking agent, propranolol. In the presence of combined parasympathetic, alpha- and beta-adrenergic blockade, the FHR remained essentially constant during the hypogastric artery occlusions in non-acidemic fetuses. FHR decelerations persisted after parasympathetic or total autonomic blockade when the fetuses were significantly hypoxic, as judged by depressed arterial blood pH and base excess values. Beat-to-beat variability of the baseline FHR persisted in the face of severe hypoxia and acidosis. These observations demonstrate that reflex mechanisms are involved importantly in the genesis of late deceleration FHR patterns in the acutely hypoxemic fetus, but that direct depression of myocardial rhythmicity becomes a factor as hypoxic acidosis develops.     

The effect of maternal hyperoxia on breathing movements, body movements and rest-activity cycles of low-risk human fetuses

The effects of maternal hyperoxia on fetal breathing and body movements, and on fetal activity state as reflected in the fetal heart rate pattern, were studied in 20 healthy gravida. Fetal breathing and trunk movements were observed by means of real-time ultrasound scanning, and the fetal heart rate was recorded continuously before, during and after 30 min of maternal oxygen inhalation by mask. Maternal transcutaneous oxygen tension (TcPO2) was measured in 9 subjects. The protocol was also carried out in ten of the gravidas with substitution of compressed air for oxygen. Maternal TcPO2 nearly doubled during oxygen breathing in the subjects in whom this was measured. There were no significant changes in the incidence of fetal breathing or trunk movements, or in the distribution of heart rate patterns, during maternal oxygen breathing. Also, no differences were observed in these variables between the oxygen and compressed-air experiments. We conclude that the normal level of fetal oxygenation does not limit fetal activity in uncomplicated pregnancies.     

Combined (stressed and non-stressed) antenatal fetal heart rate monitoring.

Acceleration patterns of the fetal heart rate, or a normal heart rate during spontaneous contractions, were used as a short weekly screening test to evaluate fetal well-being in 1102 high-risk pregnancies. When accelerations or contractions were absent during the initial screening, oxytocin was administered to stimulate uterine contractions. The mean duration of the antenatal monitoring was 18.5 min when the initial antenatal monitoring was normal, but 38.8 min when the initial results were uncertain. Oxytocin was administered to 38% of patients. This reduced the number of occasions where the diagnosis was uncertain from 46.6% to 12%. Patients with uncertain antenatal fetal monitoring had significantly more late decelerations during labor as well as newborns with low Apgar scores when compared to those with normal antenatal monitoring. Patients with abnormal antenatal monitoring (positive stress test) had significantly more low 5-min Apgar scores, late decelerations during labor and growth-retarded infants than the patients with normal antenatal fetal monitoring. Only 1 intrauterine death occurred within 7 days of a normal antenatal heart rate recording. No preventable fetal deaths occurred when antenatal monitoring demonstrated an acceleration pattern of the fetal heart rate.     

Fetal heart rate pattern and risk for respiratory disturbance in full-term newborns

Etiologic and pathogenetic factors responsible for respiratory disturbances in full-term infants are still unclear. The authors' intention was to analyze to what extent fetal stress, expressed in terms of abnormal fetal heart rate pattern, was reflected in neonatal respiratory disturbance. The study was performed prospectively over one year and included 157 term infants. Contrary to general belief, there was a significantly lower incidence of respiratory disturbances after ominous fetal heart rate pattern, ie, basal bradycardia, late or severe variable decelerations, and reduced variability than after a normal fetal heart rate pattern. It is suggested that these results may be due to a favorable effect on the fetal lung of systemic or local factors, produced in response to intrauterine stress.     

Intrapartum fetal heart rate patterns in the prediction of neonatal acidemia

OBJECTIVE: This study was undertaken to correlate changes in the intrapartum electronic fetal heart rate patterns with the development of significant neonatal acidemia. STUDY DESIGN: We identified 488 fetuses at a gestational age of >37 weeks' gestation who had continuous electronic fetal monitoring during labor for the last 2 hours and umbilical artery cord gas analysis performed at delivery. One investigator blinded to the cord gas outcome reviewed all 488 tracings using the National Institute of Child Health and Human Development guidelines for fetal heart rate monitoring. All fetal heart rate tracings with bradycardia were removed from further analysis. The patients were placed in six groups, depending on the absence or presence of normal variability (amplitude >5 beats) during the last hour of monitoring combined with the absence of decelerations or the presence of variable or late decelerations. The relationship between changes in variability and the outcome variables of pH and base deficit in the six groups was assessed with analysis of variance and chi(2) test. Significance was set at the P <.05 level. RESULTS: Patients with normal variability and accelerations, even in the presence of late decelerations or variable decelerations, maintained an umbilical artery pH 7.0 or greater in more than 97% of cases. In the presence of minimal/absent variability (amplitude <5) for at least an hour, the incidence of significant acidemia (pH <7.0) ranged from (12%-31%). CONCLUSION: The most significant intrapartum fetal heart rate parameter to predict the development of significant acidemia is the presence of minimal/absent variability for at least 1 hour as a solitary abnormal finding or in conjunction with late decelerations in the absence of accelerations. Urgent delivery should be considered in these cases after appropriate ancillary testing.